Press "Enter" to skip to content

Sree Chitra Hospital: US Patent for Sree Chithra Hospital – Yellow Throat

Latest News

Thiruvananthapuram: The US Patent for Trivandrum Sree Chithra Hospital, which invented a drug for most cancers from turmeric The US Patent has been awarded a brand new drug developed by the Sri Chitra Thirunal Institute of Medical Sciences and Technology. The patent was derived from a pancreas developed with a turmeric protein that helps forestall the unfold of contaminated tumor to different areas.


Also Read:
Senkumar's grievance towards Sree Chithra Institute: A 3 member committee comprising Jacob Thomas

Curcumin, a serious element of turmeric, has already been discovered to have most cancers immunity. But the Sree Chitra Hospital has discovered a system of curcumin within the physique of the affected person within the type of an easy-to-use wafer. This substance additionally helps in clotting. Once used, curcumin within the wafer will keep within the physique for a time frame. In addition to curcumin, wafer additionally accommodates one other protein, albumin. When albumin is blocked by most cancers cells, curcumin quickly spreads into the physique. The physique itself then eliminates the fibrin wafer.

Also Read:
'Strict legislation to cope with baby molesting dad and mom'

After surgical removing of cancerous tumors, curcumin must be used to forestall most cancers unfold to different components of the physique. The new system has been developed with the assistance of the Indian Council of Medical Research, which works on well being analysis. There are additionally indications that the patents could also be handed over to the ICMR to facilitate future improvement within the area.

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)(0); if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

fbq('init', '459529110917769'); fbq('track', "PageView");

Disclaimer - OBN is an informational website which aims to give the latest blockchain related news to the readers. Articles on OBN should not be considered as investment advice. Trading cryptocurrencies is a high-risk investment, every user is advised to consult an expert before making any decisions.